Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSPORT: Bevacizumab in NSCLC with Brain Metastases
NCT00312728Phase 2Completed
- Sponsor
- Genentech
- Start
- Mar 2006
- Primary completion
- Jun 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Genentech. Started Mar 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT00312728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312728.